Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.38% | -7.88% | |||
| Total Other Revenue | -- | 315.54% | |||
| Total Revenue | 12.66% | -5.87% | |||
| Cost of Revenue | 13.75% | -7.40% | |||
| Gross Profit | 4.35% | 7.73% | |||
| SG&A Expenses | 3.56% | -0.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -50.04% | 111.31% | |||
| Total Operating Expenses | 12.06% | -6.27% | |||
| Operating Income | 32.12% | 9.71% | |||
| Income Before Tax | 63.03% | 4.00% | |||
| Income Tax Expenses | 9.26% | 10.99% | |||
| Earnings from Continuing Operations | 92.12% | 0.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -8.12% | -36.57% | |||
| Net Income | 151.76% | -15.28% | |||
| EBIT | 32.12% | 9.71% | |||
| EBITDA | 26.32% | 13.46% | |||
| EPS Basic | 152.51% | -15.77% | |||
| Normalized Basic EPS | 106.99% | -30.34% | |||
| EPS Diluted | 158.41% | -17.69% | |||
| Normalized Diluted EPS | 106.99% | -30.34% | |||
| Average Basic Shares Outstanding | -0.43% | 0.87% | |||
| Average Diluted Shares Outstanding | -0.43% | 0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.21% | -0.66% | |||